Skip to content
PubMed This is a summary of 81 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 81 referenced papers

Top Authors

Gholamreza Daryabor
Shiraz University of Medical Sciences
Kurosh Kalantar
Shiraz University of Medical Sciences
Bart J. Currie
Royal Darwin Hospital
Direk Limmathurotsakul
Mahidol Oxford Tropical Medicine Research Unit
Chiranjay Mukhopadhyay
Kasturba Medical College, Manipal
Narisara Chantratita
Mahidol University
Josh Hanson
Cairns Hospital
David A. B. Dance
Derriford Hospital
Robert Norton
Townsville Hospital
W. Joost Wiersinga
Amsterdam Neuroscience

Top Institutions

Ranked by publications Top 10 institutions
04

Centers for Disease Control and Prevention

Atlanta, United States

40 papers
09

United States Army Medical Research Institute of Infectious Diseases

Frederick, United States

30 papers

References

References (81)
  1. 1

    Land use and soil type determine the presence of the pathogen Burkholderia pseudomallei in tropical rivers.

    Ribolzi O, Rochelle-Newall E, Dittrich S, et al.

    Environmental science and pollution research international 2016; (23(8)):7828-39 doi:10.1007/s11356-015-5943-z.

    PMID: 26758304
  2. 2

    Seroprevalence of Burkholderia pseudomallei among Adults in Coastal Areas in Southwestern India.

    Vandana KE, Mukhopadhyay C, Tellapragada C, et al.

    PLoS neglected tropical diseases 2016; (10(4)):e0004610 doi:10.1371/journal.pntd.0004610.

    PMID: 27078156
  3. 3

    Evaluation of the Bruker Biotyper Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry System for Identification of Clinical and Environmental Isolates of Burkholderia pseudomallei.

    Wang H, Chen YL, Teng SH, et al.

    Frontiers in microbiology 2016; (7()):415 doi:10.3389/fmicb.2016.00415.

    PMID: 27092108
  4. 4

    Possible misidentification of species in the Pseudomonas fluorescens lineage as Burkholderia pseudomallei and Francisella tularensis, and emended descriptions of Pseudomonas brenneri,Pseudomonas gessardii and Pseudomonas proteolytica.

    van den Beld MJC, Reinders E, Notermans DW, Reubsaet FAG

    International journal of systematic and evolutionary microbiology 2016; (66(9)):3420-3425 doi:10.1099/ijsem.0.001206.

    PMID: 27259517
  5. 5

    Loss of Methyltransferase Function and Increased Efflux Activity Leads to Doxycycline Resistance in Burkholderia pseudomallei.

    Webb JR, Price EP, Currie BJ, Sarovich DS

    Antimicrobial agents and chemotherapy 2017; (61(6)) doi:10.1128/AAC.00268-17.

    PMID: 28348161
  6. 6

    Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for the identification of Burkholderia pseudomallei from Asia and Australia and differentiation between Burkholderia species.

    Suttisunhakul V, Pumpuang A, Ekchariyawat P, et al.

    PloS one 2017; (12(4)):e0175294 doi:10.1371/journal.pone.0175294.

    PMID: 28384252
  7. 7

    Entry, Intracellular Survival, and Multinucleated-Giant-Cell-Forming Activity of Burkholderia pseudomallei in Human Primary Phagocytic and Nonphagocytic Cells.

    Whiteley L, Meffert T, Haug M, et al.

    Infection and immunity 2017; (85(10)) doi:10.1128/IAI.00468-17.

    PMID: 28760929
  8. 8

    A simple laboratory algorithm for diagnosis of melioidosis in resource-constrained areas: a study from north-central Vietnam.

    Trinh TT, Hoang TS, Tran DA, et al.

    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2018; (24(1)):84.e1-84.e4 doi:10.1016/j.cmi.2017.07.029.

    PMID: 28780059
  9. 9

    Melioidosis in lower provincial Cambodia: A case series from a prospective study of sepsis in Takeo Province.

    Schully KL, Berjohn CM, Prouty AM, et al.

    PLoS neglected tropical diseases 2017; (11(9)):e0005923 doi:10.1371/journal.pntd.0005923.

    PMID: 28902844
  10. 10

    Presence of Burkholderia pseudomallei in Soil and Paddy Rice Water in a Rice Field in Northeast Thailand, but Not in Air and Rainwater.

    Ong CEL, Wongsuvan G, Chew JSW, et al.

    The American journal of tropical medicine and hygiene 2017; (97(6)):1702-1705 doi:10.4269/ajtmh.17-0515.

    PMID: 29016340
  11. 11

    Influence of Biochemical Features of Burkholderia pseudomallei Strains on Identification Reliability by Vitek 2 System.

    Zakharova IB, Lopasteyskaya YA, Toporkov AV, Viktorov DV

    Journal of global infectious diseases 2018; (10(1)):7-10 doi:10.4103/jgid.jgid_39_17.

    PMID: 29563716
  12. 12

    Impact of nutritional stress on drug susceptibility and biofilm structures of Burkholderia pseudomallei and Burkholderia thailandensis grown in static and microfluidic systems.

    Anutrakunchai C, Bolscher JGM, Krom BP, et al.

    PloS one 2018; (13(3)):e0194946 doi:10.1371/journal.pone.0194946.

    PMID: 29579106
  13. 13

    Burkholderia pseudomallei infection presenting with a lung abscess and osteomyelitis in an adult man: A case report.

    Huang L, Yang Z, Zhou XP, Wu JR

    Medicine 2018; (97(35)):e12145 doi:10.1097/MD.0000000000012145.

    PMID: 30170455
  14. 14

    Clinical presentation and treatment of melioidosis in the head and neck region.

    Mahawerawat K, Kasemsiri P

    The Journal of laryngology and otology 2018; (132(9)):827-831 doi:10.1017/S0022215118001391.

    PMID: 30180912
  15. 15

    Melioidosis in South Asia (India, Nepal, Pakistan, Bhutan and Afghanistan).

    Mukhopadhyay C, Shaw T, Varghese GM, Dance DAB

    Tropical medicine and infectious disease 2018; (3(2)) doi:10.3390/tropicalmed3020051.

    PMID: 30274447
  16. 16

    Evaluation of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for identifying Burkholderia pseudomallei and Burkholderia thailandensis isolates.

    Li J, Hu W, Zhang F, et al.

    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2019; (38(1)):191-196 doi:10.1007/s10096-018-3415-3.

    PMID: 30426332
  17. 17

    Presence of Burkholderia pseudomallei in the 'Granary of Myanmar'.

    Win TT, Su KK, Than AM, et al.

    Tropical medicine and infectious disease 2019; (4(1)) doi:10.3390/tropicalmed4010008.

    PMID: 30621177
  18. 18

    The Tunnel Sign Revisited: A Novel Observation of Cerebral Melioidosis Mimicking Sparganosis.

    Peh WM, Hean GG, Clement YHR

    Journal of radiology case reports 2018; (12(8)):1-11 doi:10.3941/jrcr.v12i8.3441.

    PMID: 30651915
  19. 19

    Oral eradication therapy for melioidosis: Important but not without risks.

    Sullivan RP, Ward L, Currie BJ

    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2019; (80()):111-114 doi:10.1016/j.ijid.2019.01.019.

    PMID: 30659921
  20. 20

    Clinical Manifestations, Antimicrobial Drug Susceptibility Patterns, and Outcomes in Melioidosis Cases, India.

    Koshy M, Jagannati M, Ralph R, et al.

    Emerging infectious diseases 2019; (25(2)):316-320 doi:10.3201/eid2502.170745.

    PMID: 30666953
  21. 21

    Melioidosis with a subdural collection - a case report.

    Amarasena HLP, Silva FHDS, Tilakaratna PMYI, et al.

    BMC infectious diseases 2019; (19(1)):143 doi:10.1186/s12879-019-3782-0.

    PMID: 30755178
  22. 22

    Melioidosis: misdiagnosed in Nepal.

    Shrestha N, Adhikari M, Pant V, et al.

    BMC infectious diseases 2019; (19(1)):176 doi:10.1186/s12879-019-3793-x.

    PMID: 30782129
  23. 23

    Identification of Burkholderia pseudomallei by Use of the Vitek Mass Spectrometer.

    Gassiep I, Armstrong M, Norton RE

    Journal of clinical microbiology 2019; (57(5)) doi:10.1128/JCM.00081-19.

    PMID: 30842230
  24. 24

    Burkholderia pseudomallei Lipopolysaccharide Genotype Does Not Correlate With Severity or Outcome in Melioidosis: Host Risk Factors Remain the Critical Determinant.

    Webb JR, Sarovich DS, Price EP, et al.

    Open forum infectious diseases 2019; (6(4)):ofz091 doi:10.1093/ofid/ofz091.

    PMID: 30949536
  25. 25

    Infected aneurysm after returning from Southeast Asia: think Burkholderia pseudomallei!

    Auvens C, Neuwirth C, Piroth L, Blot M

    BMJ case reports 2019; (12(5)) doi:10.1136/bcr-2018-228856.

    PMID: 31122956
  26. 26

    Quantitative Proteomics Reveals Differences in the Response of Neutrophils Isolated from Healthy or Diabetic Subjects to Infection with Capsule-Variant Burkholderia thailandensis.

    Withatanung P, Kurian D, Tangjittipokin W, et al.

    Journal of proteome research 2019; (18(7)):2848-2858 doi:10.1021/acs.jproteome.9b00166.

    PMID: 31244210
  27. 27

    Fatal deep venous thrombosis and pulmonary embolism secondary to melioidosis in China: case report and literature review.

    Wu H, Huang D, Wu B, et al.

    BMC infectious diseases 2019; (19(1)):984 doi:10.1186/s12879-019-4627-6.

    PMID: 31752745
  28. 28

    Hepatic/splenic abscess and/or skin and soft tissue infection as predictors of melioidosis in children.

    Chanvitan S, Geater A, Laoprasopwattana K

    Journal of infection in developing countries 2019; (13(2)):149-153 doi:10.3855/jidc.10727.

    PMID: 32036350
  29. 29

    Melioidosis: A Neglected Cause of Community-Acquired Pneumonia.

    Virk HS, Mukhopadhyay C, Wiersinga WJ

    Seminars in respiratory and critical care medicine 2020; (41(4)):496-508 doi:10.1055/s-0040-1710570.

    PMID: 32629488
  30. 30

    A Comparison Between 12 Versus 20 Weeks of Trimethoprim-sulfamethoxazole as Oral Eradication Treatment for Melioidosis: An Open-label, Pragmatic, Multicenter, Non-inferiority, Randomized Controlled Trial.

    Anunnatsiri S, Chaowagul W, Teparrukkul P, et al.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2021; (73(11)):e3627-e3633 doi:10.1093/cid/ciaa1084.

    PMID: 32725199
  31. 31

    The Effects of Type 2 Diabetes Mellitus on Organ Metabolism and the Immune System.

    Daryabor G, Atashzar MR, Kabelitz D, et al.

    Frontiers in immunology 2020; (11()):1582 doi:10.3389/fimmu.2020.01582.

    PMID: 32793223
  32. 32

    Burkholderia pseudomallei sepsis with osteoarticular melioidosis of the hip in a patient with diabetes mellitus.

    Boyer PN, Woods ML

    BMJ case reports 2020; (13(12)) doi:10.1136/bcr-2020-238200.

    PMID: 33370949
  33. 33

    Antimicrobial Susceptibility of Western Hemisphere Isolates of Burkholderia pseudomallei: Phenotypic and Genomic Analyses.

    Bugrysheva JV, Lascols C, McLaughlin HP, et al.

    Microbial drug resistance (Larchmont, N.Y.) 2021; (27(9)):1176-1185 doi:10.1089/mdr.2020.0362.

    PMID: 33570476
  34. 34

    Comparative virulence of three different strains of Burkholderia pseudomallei in an aerosol non-human primate model.

    Trevino SR, Dankmeyer JL, Fetterer DP, et al.

    PLoS neglected tropical diseases 2021; (15(2)):e0009125 doi:10.1371/journal.pntd.0009125.

    PMID: 33571211
  35. 35

    Antibiotic susceptibility of clinical Burkholderia pseudomallei isolates in northeast Thailand during 2015-2018 and the genomic characterization of β-lactam-resistant isolates.

    Fen SHY, Tandhavanant S, Phunpang R, et al.

    Antimicrobial agents and chemotherapy 2023; (95(5)) doi:10.1128/AAC.02230-20.

    PMID: 33593842
  36. 36

    Diagnosis of melioidosis: the role of molecular techniques.

    Gassiep I, Burnard D, Bauer MJ, et al.

    Future microbiology 2021; (16()):271-288 doi:10.2217/fmb-2020-0202.

    PMID: 33595347
  37. 37

    Misidentification of Burkholderia pseudomallei, China.

    Wu B, Tong X, He H, et al.

    Emerging infectious diseases 2021; (27(3)):964-966 doi:10.3201/eid2703.191769.

    PMID: 33622484
  38. 38

    The regulatory role of insulin in energy metabolism and leukocyte functions.

    Cruz-Pineda WD, Parra-Rojas I, Rodríguez-Ruíz HA, et al.

    Journal of leukocyte biology 2022; (111(1)):197-208 doi:10.1002/JLB.2RU1220-847R.

    PMID: 33724523
  39. 39

    Geographical distribution of Burkholderia pseudomallei in soil in Myanmar.

    Swe MMM, Win MM, Cohen J, et al.

    PLoS neglected tropical diseases 2021; (15(5)):e0009372 doi:10.1371/journal.pntd.0009372.

    PMID: 34029325
  40. 40

    Melioidosis in Critical Care: A Review.

    Sridharan S, Princess IB, Ramakrishnan N

    Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine 2021; (25(Suppl 2)):S161-S165 doi:10.5005/jp-journals-10071-23837.

    PMID: 34345132
  41. 41

    Nocardiosis in Immunocompromised Patients on Alternative Pneumocystis Prophylaxis.

    Puing AG, Epstein DJ, Banaei N, et al.

    Emerging infectious diseases 2021; (27(10)):2734-2736 doi:10.3201/eid2710.210620.

    PMID: 34545802
  42. 42

    Generation of Distinct Differentially Culturable Forms of Burkholderia following Starvation at Low Temperature.

    Auty JM, Jenkins CH, Hincks J, et al.

    Microbiology spectrum 2022; (10(1)):e0211021 doi:10.1128/spectrum.02110-21.

    PMID: 34985335
  43. 43

    Genomic Epidemiology Links Burkholderia pseudomallei from Individual Human Cases to B. pseudomallei from Targeted Environmental Sampling in Northern Australia.

    Webb JR, Mayo M, Rachlin A, et al.

    Journal of clinical microbiology 2022; (60(3)):e0164821 doi:10.1128/JCM.01648-21.

    PMID: 35080450
  44. 44

    Burkholderia pseudomallei pathogenesis in human skin fibroblasts: A Bsa type III secretion system is involved in the invasion, multinucleated giant cell formation, and cellular damage.

    Kaewpan A, Duangurai T, Rungruengkitkun A, et al.

    PloS one 2022; (17(2)):e0261961 doi:10.1371/journal.pone.0261961.

    PMID: 35113856
  45. 45

    The Epidemiology of Melioidosis and Its Association with Diabetes Mellitus: A Systematic Review and Meta-Analysis.

    Chowdhury S, Barai L, Afroze SR, et al.

    Pathogens (Basel, Switzerland) 2022; (11(2)) doi:10.3390/pathogens11020149.

    PMID: 35215093
  46. 46

    Laboratory Investigations in Patients with Community Acquired Sepsis and/or Pneumonia Caused by Burkholderia pseudomallei.

    Behera B, Radhakrishnanan A, Mishra B, et al.

    The American journal of tropical medicine and hygiene 2022;.

    PMID: 35344934
  47. 47

    Analysis of the Clinical Characteristics of Hyponatremia Induced by Trimethoprim/Sulfamethoxazole.

    Lei H, Liu X, Zeng J, et al.

    Pharmacology 2022; (107(7-8)):351-358 doi:10.1159/000523824.

    PMID: 35381593
  48. 48

    Comprehensive approaches for the detection of Burkholderia pseudomallei and diagnosis of melioidosis in human and environmental samples.

    Oslan SNH, Yusoff AH, Mazlan M, et al.

    Microbial pathogenesis 2022; (169()):105637 doi:10.1016/j.micpath.2022.105637.

    PMID: 35710088
  49. 49

    TLR9 Negatively Regulates Intracellular Bacterial Killing by Pyroptosis in Burkholderia pseudomallei-Infected Mouse Macrophage Cell Line (Raw264.7).

    Pudla M, Sanongkiet S, Ekchariyawat P, et al.

    Microbiology spectrum 2022; (10(5)):e0348822 doi:10.1128/spectrum.03488-22.

    PMID: 36194127
  50. 50

    The Risks of Using Trimethoprim/Sulfamethoxazole in Patients with Renal and Cardiac Compromise.

    Hoffman AF, Lin TL

    Journal of the American Podiatric Medical Association 2022; (112(5)).

    PMID: 36251600
  51. 51

    Pathogenicity and virulence of Burkholderia pseudomallei.

    Bzdyl NM, Moran CL, Bendo J, Sarkar-Tyson M

    Virulence 2022; (13(1)):1945-1965 doi:10.1080/21505594.2022.2139063.

    PMID: 36271712
  52. 52

    Workflow for Identification of Burkholderia pseudomallei Clinical Isolates in Myanmar.

    Aung NM, Su KK, Chantratita N, Tribuddharat C

    Japanese journal of infectious diseases 2023; (76(2)):106-112 doi:10.7883/yoken.JJID.2022.508.

    PMID: 36450576
  53. 53

    Burkholderia pseudomallei in soil and natural water bodies in rural Sri Lanka: A hidden threat to public health.

    Jayasinghearachchi HS, Muthugama TA, Masakorala J, et al.

    Frontiers in veterinary science 2022; (9()):1045088 doi:10.3389/fvets.2022.1045088.

    PMID: 36733425
  54. 54

    Craniospinal MRI Findings in Neuromelioidosis.

    Naik S, Bhoi SK, Jha M, Kumar M

    Neurology India 2023; (71(1)):113-118 doi:10.4103/0028-3886.370442.

    PMID: 36861583
  55. 55

    Travel-associated melioidosis: a narrative review.

    Norman FF, Chen LH

    Journal of travel medicine 2023; (30(3)) doi:10.1093/jtm/taad039.

    PMID: 36971472
  56. 56

    The Expanding Global Footprint of Burkholderia pseudomallei and Melioidosis.

    Currie BJ, Meumann EM, Kaestli M

    The American journal of tropical medicine and hygiene 2023; (108(6)):1081-1083 doi:10.4269/ajtmh.23-0223.

    PMID: 37160279
  57. 57

    Melioidosis as a Mystique Infection: A Study From Central India.

    Yadav V, Pawar A, Meena M, et al.

    Cureus 2023; (15(8)):e43439 doi:10.7759/cureus.43439.

    PMID: 37711937
  58. 58

    Burkholderia pseudomallei and melioidosis.

    Meumann EM, Limmathurotsakul D, Dunachie SJ, et al.

    Nature reviews. Microbiology 2024; (22(3)):155-169 doi:10.1038/s41579-023-00972-5.

    PMID: 37794173
  59. 59

    Synchronous detection of Burkholderia pseudomallei and its ceftazidime resistance mutation based on RNase-HII hydrolysis combined with lateral flow strip assay.

    Yao J, Zhang Z, Tian S, et al.

    Microbiology spectrum 2023; (11(6)):e0112523 doi:10.1128/spectrum.01125-23.

    PMID: 37815337
  60. 60

    Showing the limitations of available phenotypic assays to detect Burkholderia pseudomallei from clinical specimens in Nigeria.

    Orababa OQ, Adesida SA, Peters RF, et al.

    Access microbiology 2023; (5(10)) doi:10.1099/acmi.0.000604.v5.

    PMID: 37970086
  61. 61

    The Epidemiological, Clinical, and Microbiological Features of Patients with Burkholderia pseudomallei Bacteraemia-Implications for Clinical Management.

    Prinsloo C, Smith S, Law M, Hanson J

    Tropical medicine and infectious disease 2023; (8(11)) doi:10.3390/tropicalmed8110481.

    PMID: 37999600
  62. 62

    Development of neutropenic sepsis during the eradication phase with co-trimoxazole in patients with melioidosis: two case reports.

    Jayaweera JAAS, Ranasinghe G

    Germs 2023; (13(3)):266-272 doi:10.18683/germs.2023.1393.

    PMID: 38146382
  63. 63

    Function of Burkholderia pseudomallei RpoS and RpoN2 in bacterial invasion, intracellular survival, and multinucleated giant cell formation in mouse macrophage cell line.

    Diep DTH, Vong LB, Tungpradabkul S

    Antonie van Leeuwenhoek 2024; (117(1)):39 doi:10.1007/s10482-024-01944-2.

    PMID: 38388985
  64. 64

    A case of pulmonary melioidosis in Germany: a rare differential diagnosis in returning travelers from South-East Asia.

    Gottschalk C, Stojković M, Zange S, et al.

    Infection 2024; (52(5)):1671-1676 doi:10.1007/s15010-024-02253-6.

    PMID: 38668919
  65. 65

    Dysfunctional host cellular immune responses are associated with mortality in melioidosis.

    Wright SW, Ekchariyawat P, Sengyee S, et al.

    Emerging microbes & infections 2024; (13(1)):2380822 doi:10.1080/22221751.2024.2380822.

    PMID: 39008280
  66. 66

    Bone and joint infections due to melioidosis; diagnostic and management strategies to optimise outcomes.

    Dadwal P, Bonner B, Fraser D, et al.

    PLoS neglected tropical diseases 2024; (18(7)):e0012317 doi:10.1371/journal.pntd.0012317.

    PMID: 39018296
  67. 67

    Phylogenetic and phenotypic characterization of Burkholderia pseudomallei isolates from Ghana reveals a novel sequence type and common phenotypes.

    Schully KL, Voegtly LJ, Rice GK, et al.

    Frontiers in microbiology 2024; (15()):1401259 doi:10.3389/fmicb.2024.1401259.

    PMID: 39044950
  68. 68

    Multi-systemic melioidosis.

    Nagoba BS, Dhotre SV, Rayate AS, et al.

    World journal of clinical cases 2024; (12(28)):6151-6154 doi:10.12998/wjcc.v12.i28.6151.

    PMID: 39371552
  69. 69

    Burkholderia pseudomallei BopE suppresses the Rab32-dependent defense pathway to promote its intracellular replication and virulence.

    Rao C, Zhang Z, Qiao J, et al.

    mSphere 2024; (9(11)):e0045324 doi:10.1128/msphere.00453-24.

    PMID: 39431830
  70. 70

    Adverse reactions to trimethoprim/sulfamethoxazole for melioidosis eradication therapy: An evaluation of frequency and risk factors.

    Martin GE, Bramwell J, Gadil E, et al.

    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2025; (150()):107283 doi:10.1016/j.ijid.2024.107283.

    PMID: 39521392
  71. 71

    Trimethoprim-Sulfamethoxazole-Induced Pancytopenia: A Case Report.

    Chahal J, Junko G

    Cureus 2024; (16(12)):e75113 doi:10.7759/cureus.75113.

    PMID: 39759622
  72. 72

    Drug-induced renal tubular acidosis in a patient receiving trimethoprim-sulfamethoxazole.

    Tan HL, Ee SCE, Zhao Y, Lew PS

    BMJ case reports 2025; (18(1)) doi:10.1136/bcr-2024-263500.

    PMID: 39875144
  73. 73

    Hemophagocytic Lymphohistiocytosis Secondary to Melioidosis in Paediatric Patients: A Case Series.

    Wan K, Liu Y, Chen Y, et al.

    Infection and drug resistance 2025; (18()):1561-1566 doi:10.2147/IDR.S505259.

    PMID: 40129908
  74. 74

    Melioidosis Presenting as Chronic Pneumonia With Soft Tissue Abscess in a Diabetic Patient Initially Treated for Tuberculosis: A Case Report From Vietnam.

    Nguyen HQ, Doan TT, Do TV, et al.

    Respirology case reports 2025; (13(6)):e70257 doi:10.1002/rcr2.70257.

    PMID: 40575398
  75. 75

    Disseminated Melioidosis from a Ruptured Infective Aortic Aneurysm and Pedal Ulcers to Septic Arthritis and Osteomyelitis: A Case Report.

    Jagan Sebastian J, Gnana Preethe B, Subramanian S

    Vascular specialist international 2025; (41()):20 doi:10.5758/vsi.250025.

    PMID: 40808240
  76. 76

    Rare Neuromelioidosis Case that Required Long Intensive Phase Therapy.

    Ankala S, John T, Varghese B

    Oman medical journal 2025; (40(3)):e760 doi:10.5001/omj.2025.14.

    PMID: 41244001
  77. 77

    Pulmonary Melioidosis Masquerading As Tuberculosis: A Case Report Presenting a Rare Medical Condition From Western India.

    Gaikwad N, Makashir PA, Kelkar R, et al.

    Cureus 2025; (17(10)):e95272 doi:10.7759/cureus.95272.

    PMID: 41287745
  78. 78

    Whole Genome Sequencing and Comparative Genomics of the Emerging Pathogen Burkholderia pseudomallei Isolated from Two Travel-Related Infections in Hungary.

    Henczkó J, Tóth Á, Knausz M, et al.

    Pathogens (Basel, Switzerland) 2025; (14(11)) doi:10.3390/pathogens14111108.

    PMID: 41305346
  79. 79

    Treatment of Melioidosis.

    Meumann EM, Rajahram G, Woolley SD, et al.

    Infectious disease clinics of North America 2026; (40(1)):127-147 doi:10.1016/j.idc.2025.12.002.

    PMID: 41571490
  80. 80

    Burkholderia pseudomallei in Sarawak, Malaysian Borneo, Remains Highly Susceptible to Trimethoprim-Sulfamethoxazole Despite Resistance to Its Individual Components.

    Sumbu LL, Sia TL, Ooi MH, et al.

    Pathogens (Basel, Switzerland) 2026; (15(1)) doi:10.3390/pathogens15010110.

    PMID: 41599094
  81. 81

    Tunnel sign on magnetic resonance imaging in neuromelioidosis: A systematic literature review.

    Gupta N, Singh S, Kumar TP, et al.

    New microbes and new infections 2025; (68()):101639 doi:10.1016/j.nmni.2025.101639.

    PMID: 41625698